Bristol-Myers Squibb Ownership | Who Owns Bristol-Myers Squibb?
Bristol-Myers Squibb Ownership Summary
Bristol-Myers Squibb is owned by 78.22% institutional investors, 0.08% insiders, and 21.71% retail investors. Vanguard group is the largest institutional shareholder, holding 9.37% of BMY shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.16% of its assets in Bristol-Myers Squibb shares.
BMY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bristol-Myers Squibb | 78.22% | 0.08% | 21.71% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Drug Manufacturers - General Stocks | 37.59% | 1.26% | 61.15% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 189.94M | 9.37% | $10.74B |
| Blackrock funding, inc. /de | 172.23M | 8.46% | $7.97B |
| Blackrock | 158.66M | 7.84% | $6.59B |
| Jpmorgan chase | 96.02M | 4.73% | $5.43B |
| State street | 95.14M | 4.69% | $5.38B |
| Capital investors | 66.16M | 3.25% | $3.06B |
| Charles schwab investment management | 60.30M | 2.97% | $3.41B |
| Geode capital management | 44.39M | 2.19% | $2.51B |
| Norges bank | 35.18M | 1.73% | $1.99B |
| Ameriprise financial | 32.08M | 1.58% | $1.81B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Birchview capital, lp | 323.36K | 14.86% | $14.97M |
| Chiron capital management | 286.41K | 11.54% | $13.26M |
| Independent franchise partners llp | 20.98M | 6.46% | $971.02M |
| Sector gamma as | 406.00K | 6.14% | $18.79M |
| Kahn brothers group | 550.68K | 5.12% | $25.49M |
| Colrain capital | 124.00K | 4.43% | $5.74M |
| Oaktop capital management ii | 479.99K | 3.39% | $27.15M |
| Fulcrum asset management llp | 26.93K | 2.83% | $908.59K |
| Keene & associates | 61.88K | 2.81% | $3.50M |
| Nepsis | 213.52K | 2.75% | $9.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 35.18M | 0.26% | 35.18M |
| Jpmorgan chase | 96.02M | 0.40% | 18.09M |
| Ameriprise financial | 32.08M | 0.47% | 12.01M |
| Blackrock funding, inc. /de | 172.23M | 0.15% | 10.86M |
| Qube research | 9.75M | 0.46% | 9.75M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 31.11M | 0.10% | -13.83M |
| Price t rowe associates inc /md/ | 7.53M | 0.05% | -12.71M |
| Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main | 5.81M | 0.27% | -11.27M |
| Gqg partners | 3.03M | 0.20% | -9.00M |
| Two sigma advisers, lp | 1.86M | 0.24% | -7.69M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 35.18M | 0.26% | 35.18M | $1.99B |
| Qube research | 9.75M | 0.46% | 9.75M | $451.45M |
| Capitolis liquid global markets | 939.20K | 0.32% | 939.20K | $43.48M |
| Glenmede investment management, lp | 812.67K | 0.19% | 812.67K | $37.62M |
| Leigh baldwin | 534.08K | 0.46% | 534.08K | $534.08M |
Sold Out
| Holder | Change |
|---|---|
| Hwg lp | -1.00 |
| Wiser advisor group | -1.00 |
| Macroview investment management | -1.00 |
| Aspect partners | -6.00 |
| Goalvest advisory | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2,494 | -1.46% | 1,588,605,053 | -0.15% | 78 | 1.27% | 1,137 | -10.26% | 963 | 5.02% |
| Dec 31, 2024 | 2,418 | 4.18% | 1,585,430,555 | 4.93% | 78 | 1.41% | 1,203 | 11.49% | 880 | -2.98% |
| Sep 30, 2024 | 2,292 | 4.13% | 1,507,866,452 | -1.64% | 74 | 1.30% | 1,070 | 26.48% | 890 | -14.18% |
| Jun 30, 2024 | 2,162 | -9.39% | 1,529,042,503 | 0.24% | 75 | 1.33% | 830 | -23.85% | 1,020 | 6.36% |
| Mar 31, 2024 | 2,386 | -1.57% | 1,525,375,313 | -1.27% | 75 | 1.35% | 1,090 | 20.58% | 959 | -20.15% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 64.21M | 3.16% | 47.00K |
| Vanguard Total Stock Mkt Idx Inv | 63.97M | 3.14% | -1.47M |
| Vanguard Institutional 500 Index Trust | 57.72M | 2.84% | 399.61K |
| Schwab US Dividend Equity ETF™ | 56.76M | 2.79% | -9.78K |
| Vanguard 500 Index Investor | 50.38M | 2.47% | -7.38M |
| Fidelity 500 Index | 25.79M | 1.27% | 183.20K |
| SPDR® S&P 500 ETF | 25.22M | 1.24% | -369.06K |
| SPDR® S&P 500® ETF | 24.67M | 1.21% | -102.86K |
| SPDR® S&P 500® ETF Trust | 24.55M | 1.21% | -128.84K |
| iShares Core S&P 500 ETF | 24.31M | 1.19% | 110.49K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 02, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | $16.72K |
| May 09, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | $3.70K |
| Apr 25, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | $202.22K |
| Feb 20, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Buy | $110.10K |
| Feb 14, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | $100.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | 1 |
| 2025 Q1 | 2 | - |
| 2024 Q4 | 1 | 1 |
| 2024 Q3 | - | - |
BMY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools